Freeze-drying approach to enhance antibody stability

Smilkov, Katarina and Gjorgieva Ackova, Darinka and Janevik-Ivanovska, Emilija (2015) Freeze-drying approach to enhance antibody stability. In: International Symposium at Faculty of Medical Sciences “Current achievements and future perspectives in medical and biomedical research”, 24 Nov 2015, Stip, Macedonia.

[thumbnail of Poster Kongres FMN 2015_ Katarina.pdf]
Poster Kongres FMN 2015_ Katarina.pdf

Download (373kB) | Preview
[thumbnail of book of abstracts 02012016.pdf]
book of abstracts 02012016.pdf

Download (1MB) | Preview
[thumbnail of current] Text

Download (47kB)


Preparations containing antibodies are more easily formulated in solution, but their stability is often impaired, concerning the fact that aqueous solutions are prone to numerous physical and chemical changes, Freeze-drying is often used process in biopharmaceutical production, because the chemical and physical degradation rate can be significantly reduced in dry state.
Our experience was in designing a freeze-drying process in order to formulate freeze-dried kit, containing conjugated Anti-CD-20 antibody, ready-to label with radioactive isotopes. Using freeze-dryer able to controll process parameters, (Labconco Free Zone Stoppering Tray Dryer, USA), two types of freeze-drying protocols were applied, a protocol with direct freezing to the initial temperature of -40 °C and a protocol with gradual freezing from 5 °C to -40 °C, at a rate of 0,40 °C/min. Appearance after reconstitution of the finished product and presence of aggregates were evaluated, as well as the IR and Raman spectra.
Results have shown that the protocol using gradual freezing from 5 °C to -40 °C, at a rate of 0,40 °C/min was more successful in maintaining the stability of the antibody during freeze-drying, giving clear solution after reconstitution, no presence of aggregates and IR and Raman spectra most similar to the spectra of the native conjugated form.
The research performed, enabled formulation of ready-to label anti-CD-20 antibody, intended for preclinical research for Non-Hodgkin’s lymphoma therapy.

Item Type: Conference or Workshop Item (Poster)
Subjects: Natural sciences > Biological sciences
Natural sciences > Chemical sciences
Medical and Health Sciences > Health biotechnology
Medical and Health Sciences > Health sciences
Medical and Health Sciences > Other medical sciences
Divisions: Faculty of Medical Science
Depositing User: Katarina Smilkov
Date Deposited: 27 Jan 2016 10:21
Last Modified: 27 Jan 2016 10:21

Actions (login required)

View Item View Item